Naia Pharmaceuticals
2014
FOUNDED
PRIVATE
STATUS
Corporate
LATEST DEAL TYPE
2
INVESTORS
Description
Operator of a biopharmaceutical company created to develop drugs for Short Bowel Syndrome. The company develops clinically advance drug candidates for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases enabling health care providers to treat gastrointestinal problems and disorders and reduce recovery times.
Primary Industry
Pharmaceuticals
Primary Office
- San Francisco, CA
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Naia Pharmaceuticals’s full profile, request a free trial.
Naia Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Corporate | 03-Apr-2017 | 00.00 | Completed | Startup | ||
| 2. Angel (individual) | 19-Oct-2015 | 00.00 | 00.00 | Completed | Startup | |
| 1. Corporate | Completed | Startup |
Naia Pharmaceuticals Investors (2)
Naia Pharmaceuticals Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Naia Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Evan Ng | Naia Pharmaceuticals | Board Member | 000 0000 | |
| Omar Haffar Ph.D | Self | Board Member | 000 0000 | |
| Robert Williamson III | Self | Board Member | 000 0000 | |
| Sherine Helmy | Naia Pharmaceuticals | Co-Founder & Board Member | 000 0000 |